No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪112.38 M‬CAD
‪−27.75 M‬CAD
‪70.65 M‬
Beta (1Y)


Matthew C. Coffey
Employees (FY)
Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.
Revenue to profit conversion
Debt level and coverage

See all ideas 

Summarizing what the indicators are suggesting.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ONC is 1.49 CAD — it has increased by 2.76% in the past 24 hours. Watch ONCOLYTICS BIOTECH INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange ONCOLYTICS BIOTECH INC stocks are traded under the ticker ONC.
ONC stock has fallen by 6.88% compared to the previous week, the last month showed zero change in price, over the last year ONCOLYTICS BIOTECH INC has showed a 48.80% decrease.
We've gathered analysts' opinions on ONCOLYTICS BIOTECH INC future price: according to them, ONC price has a max estimate of 9.00 CAD and a min estimate of 3.00 CAD. Watch ONC chart and read a more detailed ONCOLYTICS BIOTECH INC stock forecast: see what analysts think of ONCOLYTICS BIOTECH INC and suggest that you do with its stocks.
ONC reached its all-time high on Nov 7, 2000 with the price of 204.18 CAD, and its all-time low was 0.48 CAD and was reached on Oct 2, 2019. View more price dynamics on ONC chart.
See other stocks reaching their highest and lowest prices.
ONC stock is 4.83% volatile and has beta coefficient of −0.45. Track ONCOLYTICS BIOTECH INC stock price on the chart and check out the list of the most volatile stocks — is ONCOLYTICS BIOTECH INC there?
Today ONCOLYTICS BIOTECH INC has the market capitalization of ‪112.38 M‬, it has increased by 6.67% over the last week.
Yes, you can track ONCOLYTICS BIOTECH INC financials in yearly and quarterly reports right on TradingView.
ONCOLYTICS BIOTECH INC is going to release the next earnings report on Aug 13, 2024. Keep track of upcoming events with our Earnings Calendar.
ONC earnings for the last quarter are −0.09 CAD per share, whereas the estimation was −0.11 CAD resulting in a 19.80% surprise. The estimated earnings for the next quarter are −0.10 CAD per share. See more details about ONCOLYTICS BIOTECH INC earnings.
ONCOLYTICS BIOTECH INC revenue for the last quarter amounts to 0 CAD despite the estimated figure of 0 CAD. In the next quarter revenue is expected to reach 0 CAD.
ONC net income for the last quarter is ‪−6.89 M‬ CAD, while the quarter before that showed ‪−3.95 M‬ CAD of net income which accounts for −74.58% change. Track more ONCOLYTICS BIOTECH INC financial stats to get the full picture.
No, ONC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 26, 2024, the company has 27.00 employees. See our rating of the largest employees — is ONCOLYTICS BIOTECH INC on this list?
Like other stocks, ONC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCOLYTICS BIOTECH INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ONCOLYTICS BIOTECH INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ONCOLYTICS BIOTECH INC stock shows the sell signal. See more of ONCOLYTICS BIOTECH INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.